supply of inj. insulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70% soluble insulin degludec a nd 30% soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 m g salt-free anhydrous insulin aspart in 3 ml pre-filled pen /flextouch. note- five needle suitable for the use of the every five pre filled pen ] page 1 of 12 run date/time: 18/09/2026 16:07:48

North Eastern Railways has invited bids for the supply of inj. insulin degludec/insulin aspart (r-dna origin) solution for subcutaneous injection. 1 ml of the solution contains 100 units insulin degludec & insulin aspart (70% soluble insulin degludec a nd 30% soluble insulin aspart) equivalent to 2.56 mg salt-free anhydrous insulin degludec and 1.05 m g salt-free anhydrous insulin aspart in 3 ml pre-filled pen /flextouch. note- five needle suitable for the use of the every five pre filled pen ] page 1 of 12 run date/time: 18/09/2026 16:07:48 stores/north eastern rly tender document tender no: 28262005 closing date/time: 19/10/2026 11:30 divisional rly. hospital- bsb, cmm/bi/er/kolkata 600.00 ner numbers divisional rly. hospital- izn, cmm/bi/er/kolkata 650.00 - inj. insulin degludec with insulin aspart., with an EMD of ₹0.01 Cr. Please refer to the tender document for project value details. Interested bidders can submit applications until 19 October 2026, with the technical opening scheduled for 19 October 2026.